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Human Toll-like receptors (TLRs) comprise a family of proteins that recognizes pathogen-associated molecular 
patterns (PAMPs) and initiates host innate immune responses. Neutrophils, monocytes, and macrophages are 
critical cellular components of the human innate immune system. Proinflammatory cytokines, such as granulo-
cyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), macro-
phage colony-stimulating factor (M-CSF), and interferon-γ (IFN-γ), have been shown to up-regulate microbicidal 
activity in these effector cells of innate immunity. Currently, the cellular and molecular mechanisms responsible 
for these effects are not completely understood. We hypothesized that these cytokines may up-regulate TLR ex-
pression as a mechanism to facilitate microbial recognition and augment the innate immune response. Using 
quantitative realtime rt-PCR technology, we examined constitutive expression of TLR2, TLR4, TLR5, and TLR9 
mRNA and the effects of G-CSF, GM-CSF, M-CSF, and IFN-γ on TLR mRNA expression in purified populations 
of normal human neutrophils, monocytes, and monocyte-derived macrophages. Relative constitutive expression 
of TLR2, TLR4, and TLR9 was similar in neutrophils and monocytes. Constitutive expression of TLR5 was less in 
neutrophils compared to monocytes. Constitutive expression of TLR4 was greater and that of TLR9 lower in 
monocyte-derived macrophages compared to monocytes. Of the cytokines examined, IFN-γ and GM-CSF caused 
the greatest effects on TLR expression. IFN- γ up-regulated TLR2 and TLR4 in neutrophils and monocytes. 
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down-regulated by inflammatory cytokines in monocytes. These results suggest a potential role for IFN- γ 
and/or GM-CSF as therapeutic immunomodulators of the host defense to infection. 
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Introduction 
The professional phagocytes, namely neutrophils, 
monocytes and macrophages, play important roles in 
host defense as critical cellular components of the in-
nate immune system. These leukocytes have the ability 
to quickly recognize pathogens, mediate phagocytosis, 
and respond with production of reactive oxygen and 
nitrogen species, antimicrobial peptides, and inflam-
matory mediators.[1] The rapid action of the innate 
immune system depends on microbial product recog-
nition conferred by germline-encoded pattern recog-
nition receptors (PRRs), including CD14, β2-integrins, 
C-type lectins, macrophage scavenger receptors, com-
plement receptors, and the recently identified mem-
bers of the mammalian Toll-like receptor (TLRs).[2] To 
date, at least 10 human TLRs have been identified 
through DNA sequencing.[3-9] TLRs have specificity 
for highly conserved pathogen-associated molecular 
patterns (PAMPs) and may interact with other TLRs 
and/or other PRRs in recognition and subsequent in-
tracellular signaling, thereby enabling the innate im-
mune system to respond to pathogens discrimi-
nately.[10-12] After ligand interaction with TLRs, in-
tracellular signaling occurs via adaptor proteins, in-
cluding MyD88, TIRAP/Mal, TRIF and TRAM, which 
induce a downstream signaling cascade that culmi-
nates in nuclear translocation of NF-κB.[13-15]  
The expression patterns of TLRs in different cell 
types may be an important regulatory mechanism of 
the innate immune response to various pathogens. 
Flow cytometry studies have demonstrated constitu-
tive TLR expression in various tissues, especially leu-
kocytes.[16-18] TLR1, TLR2, TLR4, TLR5, and TLR6 are 
expressed on the cell surface, as well as intracellularly 
where they can be recruited to phagolysosomes. [11, 
18] Expression of TLR3, TLR7, TLR8, and TLR9 is lo-
calized predominantly to intracellular compartments Int. J. Med. Sci. 2008, 5 
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where they recognize viral and/or bacterial nucleic 
acids.[19-21] Neutrophils constitutively express all 
TLRs except TLR3, whereas monocytes appear to lack 
expression of TLR3, TLR6, TLR7, and TLR10. [18, 22, 
23] TLR3 expression is limited to endosomes of mye-
loid and monocyte-derived dendritic cells (DCs). 
Therefore, myeloid DCs are the only identified cell 
type which express the entire repertoire of TLRs. On 
the other hand, plasmacytoid DCs have more limited 
expression patterns. [22, 24] Recently, Peng et al have 
shown that regulatory T-cells express TLR8 and that 
the TLR8-MyD88 signaling pathway controls suppres-
sive function of Treg cells.[25] These findings suggest 
that the unique expression patterns of TLRs in various 
tissues are important for their functional biologic role 
in immunity. 
TLR2, TLR4, TLR5 and TLR9 play critical roles in 
innate immune recognition of bacteria (Reviewed in 
[15]). TLR1 and TLR6 contribute to discrimination of 
bacterial lipopeptides by functionally combining with 
TLR2.[26] TLR2 has been associated with recognition 
of cell wall structures of gram-positive bacilli, my-
coplasma, mycobacteria and yeast including lipopro-
teins, glycolipids, and zymosan.[27-32] TLR4 is con-
sidered fundamental to detection of LPS from 
gram-negative bacteria.[33, 34] Bacterial flagellin has 
been shown to be the ligand for TLR5, and TLR9 rec-
ognizes CpG motifs on bacterial DNA.[21, 35, 36] Bac-
terial products and proinflammatory cytokines have 
been shown to contribute to the regulation of TLR ex-
pression on monocytes and neutrophils, but the role of 
pro-inflammatory cytokines in regulation of TLR ex-
pression remains unclear and discrepant in previous 
reports.[16, 17, 22, 37-40] 
Pro-inflammatory cytokines, such as granulocyte 
colony-stimulating factor (G-CSF), granulo-
cyte-macrophage colony-stimulating factor (GM-CSF), 
macrophage colony-stimulating factor (M-CSF), and 
interferon-γ (IFN-γ), have been shown to up-regulate 
microbicidal activity of neutrophils and/or mono-
cytes/macrophages. All four of these cytokines, which 
are available in recombinant human form, have been 
proposed and considered as adjunctive immuno-
modulatory agents to treat serious or refractory infec-
tions in humans.[41, 42] Currently, the precise cellular 
and molecular mechanisms responsible for these ef-
fects are not completely understood but may poten-
tially include up-regulation of molecules involved in 
pathogen recognition, such as TLRs. Indeed, recent 
studies demonstrated that pretreatment of neutrophils 
with GM-CSF modulates TLR expression and cytokine 
responses to several TLR ligands.[37, 38] 
In this study, we systematically investigated the 
effects of G-CSF, GM-CSF, M-CSF, and IFN-γ on TLR 
mRNA expression in human leukocytes, focusing on 
the TLRs involved in bacterial recognition. Monocytes 
and neutrophils isolated from normal human blood 
were cultured in the absence and presence of these 
cytokines, and realtime rt-PCR technology was em-
ployed to quantitatively measure relative transcription 
of TLR2, TLR4, TLR5 and TLR9.  
Methods  
Isolation and culture of cells 
Human monocytes and neutrophils were isolated 
from EDTA-anticoagulated peripheral venous blood of 
normal human volunteers according to a protocol ap-
proved in advance by the Human Subjects Committee 
of the University of Washington Investigational Re-
view Board. Monocytes were isolated by negative 
immunoselection with RosetteSep Human Monocyte 
Enrichment Cocktail as described by the manufacturer 
(Stem Cell Technologies, Vancouver, Canada). Neu-
trophils were isolated from EDTA-anticoagulated 
blood by sequential sedimentation in dextran (Sigma, 
St. Louis, MO) in 0.9% sodium chloride, centrifugation 
over Histopaque-1077 (Sigma), and hypotonic lysis of 
erythrocytes, as previously described.[43] Cells were 
cultured in RPMI 1640 (BioWhittaker, Walkersville, 
MD) supplemented with 10% heat-inactivated fetal 
bovine serum (BioWhittaker), 1% L-glutamine, 1% 
HEPES, and 0.5% penicillin-streptomycin (all from 
BioWhittaker). Isolated monocytes were used imme-
diately or were incubated at 37˚C in a 5% 
CO2-controlled incubator for the designated time pe-
riod without stimuli or in the presence of recombinant 
human IFN-γ (1000 units/ml) (R&D Systems Min-
neapolis, Minnesota), recombinant human GM-CSF 
(100 ng/ml) (Immunex, Seattle, WA), recombinant 
human M-CSF (100 ng/ml) (R&D Systems), or LPS (1 
μg/ml) (Sigma). Neutrophils were used immediately 
or were incubated with recombinant human IFN- γ 
(1000 units/ml), recombinant human G-CSF (100 
ng/ml) (Amgen, Thousand Oaks, CA), recombinant 
human GM-CSF (100 ng/ml), or LPS (1 μg/ml). The 
doses of cytokines were chosen based on previous 
work in our lab that demonstrated what the doses 
yielded maximal activation of human neutrophils and 
monocytes/macrophages. [41, 44] Macrophages were 
prepared from isolated monocytes by incubation in the 
presence of M-CSF (100 ng/ml) for 7 days in Teflon 
beakers, as previously described.[45] 
Quantitative Real-Time rt-PCR 
Total cell RNA was isolated from 5 x 106 mono-
cytes or macrophages and 12 x 106 neutrophils using 
the RNeasy Minikit 50 according to instructions by the 
manufacturer (Qiagen, Valencia CA). DNAfree (Am-
bion Inc, Austin, TX) was used to remove contami-Int. J. Med. Sci. 2008, 5 
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nating DNA. Reverse transcription to prepare cDNA 
was performed with random primers (Amersham 
Pharmacia Biotech, Piscataway, NJ) and Superscript II 
(Life Technologies, Carlsbad, CA). RNAseOUT (Life 
Technologies, Carlsbad, CA) was used to inhibit ri-
bonuclease activity during reaction sequences. mRNA 
and cDNA samples were quantified by UV spectros-
copy measurements. The PCR reaction volume was 20 
μl containing 6 μl cDNA sample, 10 μl 2X Taqman 
Universal PCR Master Mix (PE Applied Biosystems, 
Foster City, CA), 0.1 μl of each primer (Biosearch 
Technologies, Inc., Novato, CA), 0.225 μl fluorogenic 
probe (Biosearch Technologies), and 3.575 μl DNAase 
free water. The oligonucletoide primers for respective 
TLRs were CTGCAAGCTGCGGAAGATAAT, TLR2; 
AGAGTTTCCTGCAATGGATCAAG, TLR4; 
GGCTTAATCACACCAATGTCACTATAG, TLR5; 
and TCTGAAGACTTCAGGCCCAACT, TLR9 for 
forward primers, and GCAGCTCTCAGATTTACCC-
AAAA, TLR2; TTATCTGAAGGTGTTGCACATTCC, 
TLR4; TTAAGACTTCCTCTTCATCACAACCTT, 
TLR5; and TGCACGGTCACCAGGTTGT, TLR9 for 
the reverse primers. The fluorogenic probes were 
CCGCTGAGCCTCGTCCATGGG, TLR2; 
TTCGTTCAACTTCCACCAAGAGCTGCCT, TLR4; 
TACACACAATATATGTCTGCAGGAGGCCCA, 
TLR5; and AGCACCCTCAACTTCACCTTGGATCT-
GTC, TLR 9. A GeneAmp 5700 Sequence Detection 
System (PE Applied Biosystems) was used to complete 
the PCR reactions and monitor chain elongation. Rela-
tive expression of TLRs was normalized to expression 
of 18s RNA. The final normalized results were calcu-
lated by dividing the relative transcript levels of the 
test genes by the relative amount of the 18s RNA. 
Statistical analysis 
Expression levels are expressed as means +/- SD. 
Comparisons between multiple groups were per-
formed by factorial analysis of variance (ANOVA). A p 
value < 0.05 was considered significant.  
Results 
Relative constitutive expression of TLR2, TLR4, TLR5, 
and TLR9 in normal human neutrophils, monocytes, 
and monocyte-derived macrophages 
Constitutive mRNA expression was measured in 
monocytes and neutrophils immediately after cell iso-
lation procedures. Expression of TLR2, TLR4, TLR5 
and TLR9 was detectable in normal human peripheral 
blood monocytes. Neutrophils had similar relative 
constitutive expression of TLR2, TLR4 and TLR9, but 
less TLR5, compared to monocytes (Figure 1).  
 
Figure 1. Relative constitutive expression of neutrophil TLR2, 
TLR4, TLR5, and TLR9 expressed as percentages of monocyte 
expression of these TLRs in normal human monocytes and 
neutrophils. mRNA was prepared from 5x10
6 monocytes (n=10 
independent healthy volunteers) or 12x10
6 neutrophils (n=5 
independent healthy volunteers) immediately following isola-
tion of cells. Quantitative real time rt-PCR technology was used 
to determine relative expression of TLRs normalized to the 
expression of 18s.  
 
Monocytes can be differentiated into macro-
phages in vitro through incubation in the presence of 
M-CSF for 7 days.[46] Macrophages that were derived 
in vitro constitutively expressed TLR2 and TLR5 at 
similar levels compared to monocytes. In contrast, 
TLR4 expression was significantly increased by 280 ± 
134 %, and TLR9 expression was decreased to barely 
detectable levels when compared to monocytes (Figure 
2).  
 
Figure 2. Relative constitutive expression of monocyte-derived 
macrophage TLR2, TLR4, TLR5, and TLR9 expressed as per-
centages of monocyte expression of these TLRs. mRNA was 
prepared from 5x10
6 monocytes (n=10 independent healthy 
volunteers) immediately following isolation of cells. Macro-
phages were prepared from monocytes by incubation in the 
presence of M-CSF (100ng/ml) for 7 days. mRNA was prepared 
from 5x10
6 macrophages (n=6 independent healthy volunteers). 
Quantitative real time rt-PCR technology was used to determine 
relative expression of TLRs normalized to the expression of 18s. 
Repeated measures ANOVA was used for statistical analysis. * 
indicate statistical significance with P<0.05.  
 Int. J. Med. Sci. 2008, 5 
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Modulation of TLR2, TLR4, TLR5, and TLR9 expres-
sion in normal human monocytes by IFN-γ, GM-CSF, 
and M-CSF  
Monocytes were isolated and purified from hu-
man peripheral blood and then incubated in the pres-
ence of stimulatory cytokines. Incubation with IFN-γ 
for 3 hours up-regulated expression of TLR2 and TLR4 
and down-regulated TLR5 expression in monocytes. 
TLR9 expression was not affected by IFN-γ (Figure 3).  
 
 
Figure 3. Modulation of TLR expression in normal human 
monocytes by IFN-γ, GM-CSF, and M-CSF following incuba-
tion for 3-hours. mRNA was prepared from 5x10
6 monocytes 
immediately after cell isolation (constitutive expression) or after 
a three hour incubation in the presence of IFN-γ (10
3 units/ml), 
GM-CSF (100ng/ml), or M-CSF (100ng/ml). n=4 healthy nor-
mal human donors for TLR2 and TLR4. n=3 normal healthy 
donors for TLR5 and TLR9. Quantitative real time rt-PCR 
technology was used to determine relative expression of TLRs 
normalized to the expression of 18s. Repeated measures 
ANOVA was used for statistical analysis. * indicate statistical 
significance with P<0.05. 
 
Following a 3-hour incubation with GM-CSF, 
monocytes had increased expression of TLR2 and de-
creased expression of TLR5. TLR2 was significantly 
increased by 740 ± 180 %. TLR4 and TLR9 levels were 
not affected by GM-CSF (Figure 3).  
Monocyte TLR2 and TLR5 expression was also 
a f f e c t e d  b y  a  3 - h o u r  i n c u b a t i o n  w i t h  M - C S F .  T L R 2  
expression was up-regulated by 450 ± 100 %. TLR5 was 
down-regulated, while expression of TLR4 and TLR9 
was not altered (Figure 3).  
After a 24-hour incubation, LPS had a robust ef-
fect on the expression of monocyte TLR2, with 
upregulation by 450 ± 160%. IFN-γ and GM-CSF did 
not maintain increased expression of TLR2 as seen 
after the 3-hour incubation, and the levels of expres-
sion had returned to the baseline constitutive expres-
sion of unstimulated monocytes at time zero. M-CSF 
caused a trend toward increased TLR2 expression and 
maintained TLR5 levels at initial constitutive levels. 
IFN-γ, GM-CSF and LPS all led to decreased levels of 
TLR5. TLR9 expression was at initial constitutive levels 
at 24 hours following incubation with each of the cy-
tokines whereas LPS stimulation resulted in a trend to 
reduced levels (Figure 4). 
  
 
Figure 4. Modulation of TLR expression in normal human 
monocytes by IFN-γ, GM-CSF, M-CSF or LPS following in-
cubation for 24-hours expressed as percentages of constitutive 
monocyte expression at time zero. mRNA was prepared from 
5x10
6 monocytes immediately after cell isolation (constitutive 
expression) or following a 24-hour incubation in the absence or 
presence of IFN-γ (10
3 units/ml), GM-CSF (100ng/ml), M-CSF 
(100ng/ml) or LPS (1μg/ml). n=4 healthy normal human donors 
for TLR2 and TLR9. n=5 normal healthy donors for TLR4 and 
TLR5. Quantitative real time rt-PCR technology was used to 
determine relative expression of TLRs normalized to the ex-
pression of 18s. Repeated measures ANOVA was used for 
statistical analysis. * indicate statistical significance with 
P<0.05. 
 
Modulation of TLR2, TLR4, TLR5, and TLR9 expres-
sion in normal human neutrophils by IFN-γ, GM-CSF, 
and G-CSF  
Human peripheral blood neutrophils were 
evaluated for changes in expression of TLR2, TLR4, 
TLR5, and TLR9 following incubation with 
pro-inflammatory cytokines. Short term (3-hour) in-
cubation with IFN-γ up-regulated expression of TLR2, 
TLR4 and TLR5 in neutrophils by 237 ± 80 %, 307 ± 87 
% and 417 ± 130 %, respectively. In contrast, IFN-γ 
down-regulated TLR9 expression in neutrophils (Fig-
ure 5).   
A 3-hour incubation with G-CSF up-regulated 
expression of all four TLRs in neutrophils (Figure 5). 
Specifically, G-CSF induced up-regulation of TLR2 
expression by 182 ± 44 %, TLR 4 expression by 303 ± 74 
%, TLR5 expression by 318 ± 96 %, and TLR9 expres-
sion by 192 ± 92 %. 
GM-CSF also strongly up-regulated neutrophil 
TLR2 (292 ± 105 %) and TLR4 412 ± 147 %) expression 
in neutrophils. TLR9 expression was up-regulated to a 
lesser extent. In contrast to IFN-γ and G-CSF, GM-CSF 
induced a strong down-regulation in TLR5 expression 
after a 3-hour incubation (Figure 5).   Int. J. Med. Sci. 2008, 5 
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Figure 5. Modulation of TLR expression in normal human 
neutrophils by IFN-γ, G-CSF, and GM-CSF following incuba-
tion for 3-hours expressed as percentages of constitutive neu-
trophil expression. mRNA was prepared from 12x10
6 neutro-
phils immediately after cell isolation (constitutive expression) 
or after a three hour incubation in the presence of IFN-γ (10
3 
units/ml), G-CSF (100ng/ml), or GM-CSF (100ng/ml). n=4 
healthy normal human donors for TLR2 and TLR4. n=3 normal 
healthy donors for TLR5 and TLR9. Quantitative real time 
rt-PCR technology was used to determine relative expression of 
TLRs normalized to the expression of 18s. Repeated measures 
ANOVA was used for statistical analysis. * indicate statistical 
significance with P<0.05. 
Neutrophil TLR expression patterns were also 
measured after a 24-hour incubation. Cytokine stimu-
lated cell preparations were compared to both baseline 
(time zero) constitutive expression and unstimulated 
cells at 24hours since neutrophils undergo rapid 
apoptosis soon after isolation. After a 24-hour incuba-
tion, expression of TLR2 and TLR4 declined in neu-
trophils maintained in culture in the absence of cyto-
kine supplementation. Specifically, TLR2 and TLR4 
expression decreased by 76 ± 9.5 % and 78 ± 10 %, re-
spectively. Incubation with G-CSF, GM-CSF, or LPS 
did not affect the decline in TLR4 expression. In con-
trast, TLR4 expression was maintained at baseline 
constitutive levels after incubation with IFN-γ. TLR2 
expression was maintained at initial constitutive levels 
when neutrophils were incubated for 24 hours in the 
presence of IFN-γ, G-CSF or GM-CSF. LPS increased 
TLR2 expression above the initial constitutive expres-
sion level by 390 ± 170 % (Figure 6). 
 
Figure 6. Modulation of TLR expression in normal human 
neutrophils by IFN-γ, G-CSF, GM-CSF or LPS following in-
cubation for 24-hours expressed as percentages of constitutive 
neutrophil expression. mRNA was prepared from 12x10
6 neu-
trophils immediately after cell isolation or following a 24-hour 
incubation in the absence or presence of IFN-γ (10
3 units/ml), 
G-CSF (100ng/ml), GM-CSF (100ng/ml) or LPS (1μg/ml). n=3 
healthy normal human donors for TLR2 and TLR4. Quantitative 
real time rt-PCR technology was used to determine relative 
expression of TLRs normalized to the expression of 18s. Re-
peated measures ANOVA was used for statistical analysis. * 
indicate statistical significance with P<0.05. 
Discussion    
Previous studies have shown that human TLRs 
are differentially expressed in a variety of tissues.[16, 
17, 22, 23] This study examined the expression of 
TLR2, TLR4, TLR5, and TLR9 in normal primary hu-
man professional phagocytes. Constitutive expression 
of TLR2, TLR4, and TLR9 was found to be similar in 
monocytes and neutrophils, while neutrophils ex-
pressed relatively less TLR5 compared to monocytes. 
Normal human monocyte-derived macrophages had 
similar expression levels of TLR2 and TLR5 when 
compared to monocytes. In contrast, relative TLR4 
expression was increased in macrophages, and TLR9 
expression could not be detected in macrophages. Al-
though previous studies have reported expression of 
these TLRs in human neutrophils, monocytes, and/or 
macrophages, the present study is the first to describe 
and directly compare relative expression levels in all 3 
primary cell types.[22, 23, 37, 38]  
Various stimuli have been shown to regulate ex-
pression of TLRs in leukocytes, including pathogen 
structures and TLR ligands, such as araLAM and LPS, 
and pro-inflammatory cytokines, including IL-1β, 
TNF-α, GM-CSF and IFN-γ.[16, 22, 37, 38] It is plausi-
ble that an advantage in pathogen recognition is con-
ferred by controlled expression of germline-encoded 
pathogen recognition receptors by pro-inflammatory 
signaling. Recent studies revealed that expression of 
both TLR2 and TLR4 is increased in monocytes and 
neutrophils from human patients with sepsis. [47, 48] 
In these studies, ligands for either TLR2 or TLR4 failed 
to directly affect expression of TLR2 or TLR4 in 
monocytes and neutrophils from either septic patients 
or controls, suggesting the possibility that increased 
expression of TLRs in this setting may be mediated via 
by pro-inflammatory cytokines rather than TLR-ligand 
binding per se.  
The results of our study demonstrate that several 
pro-inflammatory cytokines contribute to the regula-
tion of TLR expression. Of the cytokines studied, IFN-γ 
and GM-CSF caused the most robust effects on TLR 
expression with statistically significantly increased Int. J. Med. Sci. 2008, 5 
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TLR2 expression in monocytes, a trend for increased 
TLR4 in monocytes (IFN-γ) and trends for increased 
TLR2 and TLR4 in neutrophils. These cytokines have 
been shown to increase the microbicidal activity of 
monocytes and neutrophils. [42] We hypothesize that 
the effects on TLR expression by these cytokines con-
tribute to the enhanced antimicrobial activity. Our 
study cannot evaluate this directly but previous pub-
lications support the premise that increased TLR ex-
pression enhances the effector cell response to TLR 
ligands.  
Several studies have identified an association 
between increased inflammatory activity in monocytes 
and neutrophils after TLR expression modulation by 
IFN-γ or GM-CSF. IFN-γ-primed monocytes had in-
creased TLR4 expression and also increased responses 
to LPS, as measured by NF-κB DNA binding activity 
and cytokine production (e.g., TNF-α).[39] Neutrophils 
had increased protein and mRNA expression of TLR2 
and TLR9 after incubation with GM-CSF.[38] Fur-
thermore, neutrophils pre-incubated with GM-CSF 
had increased inflammatory activity, as measured by 
IL-8 production due to signaling through various TLR 
ligands.[38] In another study, GM-CSF increased 
TLR2-mediated cytokine and superoxide anion pro-
duction in neutrophils.[37] In vivo models have also 
demonstrated an association between TLR expression 
levels controlled by proinflammatory cytokines and 
increased responses to TLR ligands. GM-CSF was 
shown to play an important role in inflammatory sig-
naling in a model of LPS-induced lung injury. Pre-
treatment of mice with an inhibitor of GM-CSF prior to 
LPS instillation caused decreased TLR4 mRNA ex-
pression, associated with decreased lung neutrophil 
and macrophage infiltration and decreased levels of 
TNF-  α and macrophage inflammatory protein-2 
(MIP2). [49] In another study using transgenic mice 
with varyingTLR4 DNA copy number, mice with in-
creased TLR4 DNA copies had increased lung in-
flammatory responses to intranasally administered 
LPS. [50] 
   While TLR2 and TLR4 were up-regulated by 
GM-CSF and IFN-γ in monocytes, TLR5 expression 
was diminished by these cytokines in monocytes and 
by GM-CSF in neutrophils. These results may high-
light the relative importance of TLR2 and TLR4 in 
anti-bacterial innate immunity surveillance. Alterna-
tively, they suggest that separate expression control of 
TLR5 by inflammatory cytokines may contribute to 
regulation of innate immunity in monocytes and neu-
trophils.  
The effects of G-CSF and M-CSF on TLR expres-
sion in neutrophils and monocytes were less striking. 
Neutrophil surface TLR2 has been shown to be in-
creased by G-CSF in previous studies.[37] The present 
study demonstrated a small increase in expression of 
TLR2 mRNA in neutrophils. Unlike IFN-γ and 
GM-CSF, only G-CSF led to increased levels of both 
TLR5 and TLR9 in neutrophils.  
This study did not evaluate the effects of im-
mune-modulating cytokines on protein expression but 
focused on the effects on TLR mRNA expression. Pro-
inflammatory cytokines may also control protein ex-
pression of TLRs on the cell surface and intracellularly 
through regulation of inhibitory RNA pathways, pro-
tein translation and post-translational processes. Our 
results show that TLR mRNA expression is regulated 
by these cytokines, and we speculate that this may 
contribute to enhanced cellular responses to patho-
gens.  
The human TLR family is a recently described 
component of the human innate immune system, and 
our knowledge of the regulation of these patho-
gen-discriminating receptors continues to evolve. This 
report demonstrates that cytokines with known ability 
to enhance microbicidal activity of phagocytes differ-
entially regulate TLR2, TLR4, TLR5 and TLR9 mRNA 
expression in neutrophils and monocytes. IFN-γ 
strongly increased the expression of the bacterial rec-
ognition receptors TLR2 and TLR4 on both neutrophils 
and monocytes. GM-CSF treatment also increased ex-
pression of TLR2 and TLR4 on neutrophils and has 
previously been shown to enhance TLR ligand re-
sponses by these cells. These results demonstrate that 
up-regulated TLR expression may be a component of 
cytokine-mediated enhancement of phago-
cyte-mediated host defense and suggest a promising 
role for IFN-γ and/or GM-CSF as therapeutic immu-
nomodulators for enhancing bacterial recognition by 
the innate immune system. 
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